Search results for: 'biopharma denali and alliance of 221b'

Molecular Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024

Powerful Intelligence for Dealmakers...

Leading deals and alliances database for the life sciences sector

The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 report provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the world's leading biopharma companies.

Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024

The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 provides comprehensive understanding and unprecedented access to clinical stage partnering agreements entered into by the world's leading biopharma companies

Distribution Deals in Diagnostics | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024

Provides comprehensive understanding and unprecedented access to the animal health agreements entered into by the world's leading biopharma companies.

Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2020 to 2024

Infectious Diseases Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024

Global Academic and Non-Profit Partnering Terms and Agreements 2019-2024 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals.